ARISTEIA CAPITAL, L.L.C. - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOT and the CUSIP is G1125A108. A total of 1 filers reported holding BIOTECH ACQUISITION COMPANY in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ARISTEIA CAPITAL, L.L.C. ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$15,392,349
+35.0%
1,524,010
+32.6%
0.31%
+55.6%
Q3 2022$11,398,000
+0.2%
1,149,0100.0%0.20%
-2.9%
Q2 2022$11,375,000
+0.4%
1,149,0100.0%0.20%
-0.5%
Q1 2022$11,329,000
+0.2%
1,149,0100.0%0.20%
+5.1%
Q4 2021$11,306,0001,149,0100.20%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q1 2023
NameSharesValueWeighting ↓
RiverPark Advisors, LLC 799,001$7,930,0002.58%
Corbin Capital Partners, L.P. 928,124$9,207,0002.29%
Cohanzick Management, LLC 799,001$7,926,0001.92%
RPO LLC 379,021$3,762,0000.91%
Arena Capital Advisors, LLC- CA 300,000$2,978,0000.90%
Alpha Wave Global, LP 532,570$5,286,0000.62%
MIZUHO SECURITIES USA LLC 444,957$4,383,0000.60%
MMCAP International Inc. SPC 599,321$5,945,0000.47%
GLAZER CAPITAL, LLC 2,285,000$22,667,0000.42%
CVI Holdings, LLC 292,563$2,904,0000.22%
View complete list of BIOTECH ACQUISITION COMPANY shareholders